{
    "id": "wrong_mix_domainrange_publicationDate_00088_2",
    "rank": 52,
    "data": {
        "url": "https://matwin.fr/en/team-showcase/dr-jean-yves-bonnefoy/",
        "read_more_link": "",
        "language": "en",
        "title": "Dr Jean-Yves BONNEFOY",
        "top_image": "https://matwin.fr/wp-content/uploads/2017/11/fav_57.png",
        "meta_img": "https://matwin.fr/wp-content/uploads/2017/11/fav_57.png",
        "images": [
            "https://matwin.fr/wp-content/uploads/2017/09/logo_default-2.png",
            "https://matwin.fr/wp-content/uploads/2017/09/logo_default-2.png",
            "https://matwin.fr/wp-content/uploads/2017/09/logo_default-2.png",
            "https://matwin.fr/wp-content/uploads/2017/10/avatar-Jean-Yves-Bonnefoy.jpg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "emmanuel.sanchez"
        ],
        "publish_date": "2017-11-25T13:46:22+01:00",
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "https://matwin.fr/wp-content/uploads/2017/11/fav_16.png",
        "meta_site_name": "Matwin | Maturation & accelerating translation with industry",
        "canonical_link": "https://matwin.fr/en/team-showcase/dr-jean-yves-bonnefoy/",
        "text": "Jean-Yves Bonnefoy is CEO of Anagenesis Biotechnologies since January 2014. He is also President of the Life Sciences Competitiveness Cluster, Alsace BioValley, Board member of biotech companies Anagenesis and SILABE and of the engineer school ESBS. He is a member of the scientific advisory board of iTeos Therapeutics and Centre de Recherche des Cordeliers. He is also member of the investment committee of the TTO, SATT Conectus. Before Anagenesis Biotechnologies he co-founded Transgene Spin-off, ElsaLys Biotech. He was for 8 years VP, R&D of Transgene SA. From 2002 to 2005, he launched and managed the Canceropole Lyon Rhône-Alpes. From 1992 to 2002, he headed the Centre d’immunologie Pierre Fabre. From 1998 to 2002, he was Director of the Immunology Department of the Glaxo-Wellcome Institute in Switzerland. From 1985 to 1987, he was scientist at the Research Centre of Schering-Plough in France. He is author and co-author of more than 200 publications and reviews (H-index 55-30-13). Jean-Yves holds a PhD in Immunology, a “Thèse 3ème cycle” in Biochemistry and followed the Senior Management Program of the London Business School, in the UK."
    }
}